Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 437

1.

Myeloid differentiation mediated through retinoic acid receptor/retinoic X receptor (RXR) not RXR/RXR pathway.

Dawson MI, Elstner E, Kizaki M, Chen DL, Pakkala S, Kerner B, Koeffler HP.

Blood. 1994 Jul 15;84(2):446-52.

2.

Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro.

Shiohara M, Dawson MI, Hobbs PD, Sawai N, Higuchi T, Koike K, Komiyama A, Koeffler HP.

Blood. 1999 Mar 15;93(6):2057-66.

3.
5.

Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro.

Kizaki M, Dawson MI, Heyman R, Elster E, Morosetti R, Pakkala S, Chen DL, Ueno H, Chao W, Morikawa M, Ikeda Y, Heber D, Pfahl M, Koeffler HP.

Blood. 1996 Mar 1;87(5):1977-84.

6.

Effects of retinoid X receptor-selective ligands on proliferation of prostate cancer cells.

de Vos S, Dawson MI, Holden S, Le T, Wang A, Cho SK, Chen DL, Koeffler HP.

Prostate. 1997 Jul 1;32(2):115-21.

PMID:
9215399
7.
8.

9-cis retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia.

Miller WH Jr, Jakubowski A, Tong WP, Miller VA, Rigas JR, Benedetti F, Gill GM, Truglia JA, Ulm E, Shirley M, et al.

Blood. 1995 Jun 1;85(11):3021-7.

10.

Activation of three distinct RXR/RAR heterodimers induces growth arrest and differentiation of neuroblastoma cells.

Giannini G, Dawson MI, Zhang X, Thiele CJ.

J Biol Chem. 1997 Oct 17;272(42):26693-701.

11.

Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.

Sun SY, Yue P, Mao L, Dawson MI, Shroot B, Lamph WW, Heyman RA, Chandraratna RA, Shudo K, Hong WK, Lotan R.

Clin Cancer Res. 2000 Apr;6(4):1563-73.

12.

Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase.

Benedetti L, Grignani F, Scicchitano BM, Jetten AM, Diverio D, Lo Coco F, Avvisati G, Gambacorti-Passerini C, Adamo S, Levin AA, Pelicci PG, Nervi C.

Blood. 1996 Mar 1;87(5):1939-50.

13.

[Effects of 9-cis retinoic acid on hematopoiesis in vitro].

Kizaki M, Nakajima H, Ikeda Y.

Rinsho Ketsueki. 1994 Mar;35(3):256-60. Japanese.

PMID:
8158845
14.

Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.

Mills KJ, Vollberg TM, Nervi C, Grippo JF, Dawson MI, Jetten AM.

Cell Growth Differ. 1996 Mar;7(3):327-37.

15.

Novel retinoic acid, 9-cis retinoic acid, in combination with all-trans retinoic acid is an effective inducer of differentiation of retinoic acid-resistant HL-60 cells.

Kizaki M, Nakajima H, Mori S, Koike T, Morikawa M, Ohta M, Saito M, Koeffler HP, Ikeda Y.

Blood. 1994 Jun 1;83(11):3289-97.

16.
17.

9-cis-retinoic acid: effects on normal and leukemic hematopoiesis in vitro.

Sakashita A, Kizaki M, Pakkala S, Schiller G, Tsuruoka N, Tomosaki R, Cameron JF, Dawson MI, Koeffler HP.

Blood. 1993 Feb 15;81(4):1009-16.

19.

Retinoid X receptor (RXR) within the RXR-retinoic acid receptor heterodimer binds its ligand and enhances retinoid-dependent gene expression.

Minucci S, Leid M, Toyama R, Saint-Jeannet JP, Peterson VJ, Horn V, Ishmael JE, Bhattacharyya N, Dey A, Dawid IB, Ozato K.

Mol Cell Biol. 1997 Feb;17(2):644-55.

20.

Suppression of squamous cell carcinoma growth and differentiation by retinoids.

Lotan R.

Cancer Res. 1994 Apr 1;54(7 Suppl):1987s-1990s. Review.

Supplemental Content

Support Center